Homocysteine (Hcy) and cognitive performance in a population sample of elderly Brazilians

Archives of Gerontology and Geriatrics

Volumn 48, Issue 2, 2009, Pages 142-145

  Tassino, Márcio ^a   Campos, Tânia Fernandes ^a   Guerra, Ricardo Oliveira ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Cognition performance; Dementia; Folic acid; Homocysteine; Hyperhomocysteinemia; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; ARTICLE; CHEMOLUMINESCENCE; COGNITION; DEMOGRAPHY; ELDERLY CARE; FEMALE; HUMAN; LOWEST INCOME GROUP; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL;

AGED; BRAZIL; BRIEF PSYCHIATRIC RATING SCALE; CROSS-SECTIONAL STUDIES; DEMENTIA; EDUCATIONAL STATUS; FEMALE; FOLIC ACID; HEALTH STATUS INDICATORS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; POVERTY AREAS; PREVALENCE; URBAN POPULATION; VITAMIN B 12;

EID: 58349109153     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2007.12.002     Document Type: Article

References (42)

1. Adunsky A., Arinzon Z., Fidelman Z., Krasniansky I., Arad M., and Gepstein R. Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study. Arch. Gerontol. Geriatr. 40 (2005) 129-138
2. Allain T.J., Wilson A.O., Gomo Z.A., Adamchak D.J., and Matenga J.A. Diet and nutritional status in elderly Zimbabweans. Age Ageing 26 (1997) 463-470
3. Almeida O.P. Mini mental state examination and the diagnosis of dementia in Brazil. Arq. Neuropsiquiatr. 56 (1998) 605-612 (in Portuguese)
4. 12 deficiency in the elderly. Annu. Rev. Nutr. 19 (1999) 357-377
5. Bergmark C., Mansoor M.A., Swedenborg J., De Faire U., Svardal A.M., and Ueland P.M. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50-effect of smoking and extent of disease. Eur. J. Vasc. Surg. 7 (1993) 391-396
6. Bertolucci P.H., Brucki S.M., Campacci S.R., and Juliano Y. The Mini-Mental State Examination in a general population: impact of educational status. Arq. Neuropsiquiatr. 52 (1994) 1-7 (in Portuguese)
7. Clarke R. Homocysteine, B vitamins, and the risk of dementia. Am. J. Clin. Nutr. 85 (2007) 329-330
8. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55 (1998) 1449-1455
9. 12 and folate deficiency in later life. Age Ageing 33 (2004) 34-41
10. Coelho Filho J.M., Marcopito L.F., and Castelo A. Medication use patterns among elderly people in urban area in Northeastern Brazil. Rev. Saude Publica 38 (2004) 557-564 (in Portuguese)
11. De Bree A., Van der Put N.M., Mennen L.I., Verschuren W.M., Blom H.J., Galan P., Bates C.J., Herrmann W., Ullrich M., Dierkes J., Westphal S., Bouter L.M., Heine R.J., Stehouwer C.D., Dekker J.M., Nijpels G.N., Araújo F., Cunha-Ribeiro L.M., Refsum H., Vollset S., Nygard O., and Ueland P.M. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur. J. Clin. Nutr. 59 (2005) 480-488
12. Donini L.M., De Felice M.R., and Cannella C. Nutritional status determinants and cognition in the elderly. Arch. Gerontol. Geriatr. 44 (2007) 143-153
13. Elias M.F., Sullivan L.M., D'Agostino R.B., Elias P.K., Jacques P.F., Selhub J., Seshadri S., Au R., Beiser A., and Wolf P.A. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am. J. Epidemiol. 162 (2005) 644-653
14. 12 blood levels in relation to cognitive performance: the Maine-Syracuse study. Psychosom. Med. 68 (2006) 547-554
15. Faraci F.M., and Lentz S.R. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 35 (2004) 345-347
16. Fernandez-Miranda C., De la Pena P., Penas M., Saiz R., Gómez P., and Gómez de la Cámara A. Hyperhomocysteinemia and treatment with antiepileptic drugs effects of different doses of folic acid. Med. Clin. (Barc.) 124 (2005) 521-524 (in Spanish)
17. Flicker L., and Ames D. Metabolic and endocrinological causes of dementia. Int. Psychogeriatr. 17 (2005) S79-S92
18. Giatti L., and Barreto S.M. Health, work, and aging in Brazil. Cad. Saude Publica 19 (2003) 759-771 (in Portuguese)
19. Haan M.N., Miller J.W., Aiello A.E., Whitmer R.A., Jagust W.J., Mungas D.M., Allen L.H., and Green R. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr. 85 (2007) 511-517
20. Hankey G.J., and Eikelboom J.W. Homocysteine and stroke. Lancet 365 (2005) 194-196
21. 12 deficiency in elderly people. J. Nutr. 132 (2002) 289-291
22. Jensen E., Dehlin O., Erfurth E.-M., Hagberg B., Samuelsson G., Svensson T., and Hultberg B. Plasma homocysteine in 80-year-olds. Relationships to medical, psychological and social variables. Arch. Gerontol. Geriatr. 26 (1998) 215-226
23. 12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur studies of successful aging. Am. J. Med. 118 (2005) 161-167
24. Kalmijn S., Launer L.J., Lindemans J., Bots M.L., Hofman A., and Breteler M.M. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am. J. Epidemiol. 150 (1999) 283-289
25. Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., and Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20 (2000) 6920-6926
26. Lehmann M., Gottfries C.G., and Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement. Geriatr. Cogn. Disord. 10 (1999) 12-20
27. Lindenbaum J., Rosenberg I.H., Wilson P.W., Stabler S.P., and Allen R.H. Prevalence of cobalamin deficiency in the Framingham elderly population. Am. J. Clin. Nutr. 60 (1994) 2-11
28. McCaddon A. Homocysteine and cognitive impairment: a case series in a general practice setting. Nutr. J. 5 (2006) 6
29. 12, folic acid and mental function in the elderly. Invest. Clin. 46 (2005) 53-63
30. Miller J.W., Green R., Ramos M.I., Allen L.H., Mungas D.M., Jagust W.J., and Haan M.N. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr. 78 (2003) 441-447
31. Nilsson K., Gustafson L., and Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int. J. Geriatr. Psychiatr. 16 (2001) 609-614
32. Ortega R.M., Redondo R., Andres P., and Eguileor I. Nutritional assessment of folate and cyanocobalamin status in a Spanish elderly group. Int. J. Vitam. Nutr. Res. 63 (1993) 17-21
33. O'Suilleabhain P.E., Sung V., Hernandez C., Lacritz L., Dewey, Bottiglieri T., and Diaz-Arrastia R. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations. Arch. Neurol. 61 (2004) 865-868
34. Parsons R.B., Waring R.H., Ramsden D.B., and Williams A.C. In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell lines. Neurotoxicology 19 (1998) 599-603
35. Prince M. Methodological issues for population-based research into dementia in developing countries. A position paper from the 10/66 Dementia Research Group. Int. J. Geriatr. Psychiatr. 15 (2000) 21-30
36. 12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 80 (2004) 114-122
37. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E., and Licastro F. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 82 (2005) 636-643
38. 6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr. 63 (1996) 306-314
39. 12 deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. Ann. Pharmacother. 36 (2002) 812-816
40. Scazufca M., Cerqueira A.T., Menezes P.R., Prince M., Vallada H.P., Miyazaki M.C., Domingos N.A., Antunes E.H., Macedo G.C., Almeida S.A., and Matsuda C.M. Epidemiological research on dementia in developing countries. Rev. Saude Publica 36 (2002) 773-778 (in Portuguese)
41. Stuhlinger M.C., Tsao P.S., Her J.H., Kimoto M., Balint R.F., and Cooke J.P. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104 (2001) 2569-2575
42. Tay S.Y., Ampil E.R., Chen C.P., and Auchus A.P. The relationship between homocysteine, cognition and stroke subtypes in acute stroke. J. Neurol. Sci. 250 (2006) 58-61